Skip to content

Vasopressin in cardiac surgery

VASOPRESSIN INFUSION IN CARDIAC SURGICAL PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION: A RANDOMISED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048218
Enrollment
36
Registered
2022-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I501- Left ventricular failure, unspecified Health Condition 2: O- Medical and Surgical Health Condition 3: I978- Other intraoperative and postprocedural complications and disorders of the circulatory system, not elsewhere classified

Interventions

Intervention1: Vasopressin: Infusion dose - 1 Unit/ ml Route- Intravenous Frequency- 1.2 ml/hour started after completion of loading dose of milrinone Duration- 24 hours post surgery Control Intervent

Sponsors

Postgraduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Planned for elective cardiac surgery with CPB and presenting with LV dysfunction preoperatively. LV dysfunction will be identified by the presence of LV EF < 50% on the last available preoperative echocardiography report, except in patients with severe mitral regurgitation where the cutoff for LV EF will be <60%.

Exclusion criteria

Exclusion criteria: Preoperative requirement of vasopressors/inotrope/mechanical circulatory support Pregnancy Patients undergoing simultaneous non cardiac surgery Patients on renal replacement therapy Patients with model for end-stage liver disease Patients taking drugs for thyroid or adrenal disease Documented peripheral vascular disease disease

Design outcomes

Primary

MeasureTime frame
Cardiac indexTimepoint: 30 minutes post cardiopulmonary bypass

Secondary

MeasureTime frame
Heart rate, blood pressure, inotrope dose, blood gas investigations, cardiac index, left ventricle myocardial performance index, left ventricle systolic, diastolic functionTimepoint: Baseline, 30 minutes post CPB, and 0, 6, 12 and 24 hours in ICU;Hospital stay, MortalityTimepoint: 30 days post-operatively;Mechanical ventilation duration, ICU stay, Incidence of atrial fibrillation, requirement of renal replacement therapy, incidence of acute mesentric ischemia, peripheral cyanosisTimepoint: During ICU stay

Countries

India

Contacts

Public ContactRajarajan Ganesan

Postgraduate Institute of Medical Education and Research

raja2n@gmail.com9815930510

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026